Search - tctmd.com

Displaying 741 - 760 of 1291

Sort: Relevancy | Date

Presentation NY Valves 2024

The Rationale for Earlier Intervention in Aortic Stenosis

Presenter: Philippe Genereux

June 06, 2024

News Conference News NY Valves 2024

Long-term Mortality After TAVI Lower With DOACs vs VKAs

Todd Neale

June 06, 2024

Presentation NY Valves 2024

Clinical Outcomes of Consecutive Patients Treated With a Novel Transfemoral Percutaneous Mitral Valve System: A Single Center Experience

Presenter: Antonio Mangieri

June 06, 2024

Presentation NY Valves 2024

Are BAV Repair and the Ross Procedure “Better” for BAV Patients?

Presenter: Ismail El-Hamamsy

June 06, 2024

Presentation NY Valves 2024

Aortic Valve Replacement in BAV: Biprosthesis for Everyone? When to Consider TAVR? Do We Need Thoughtful RCTs?

Presenter: Raj Makkar

June 06, 2024

Presentation NY Valves 2024

3D Vena Contracta Area as a Predictor of Clinical Outcomes in Transcatheter Mitral Valve Repair: A Comparative Study of MR Severity Assessment Methods

Presenter: Eun Kyoung Kim

June 06, 2024

Presentation NY Valves 2024

The Critical Role of Imaging in BAV Therapy Choices

Presenter: Hasan Jilaihawi

June 06, 2024

Presentation NY Valves 2024

Managing the BAV Valvulo-Aortopathy: Distinctive Features of BAV-AS and AR, and How to Handle the Aortopathy?

Presenter: Hector I. Michelena

June 06, 2024

Presentation NY Valves 2024

A Novel Invasive Hemodynamic Parameter (V’) to Predict Clinical Outcomes Following Mitral Transcatheter Edge-to-Edge Repair (M-TEER)

Presenter: Maryam Muhammad Ali Majeed-Saidan

June 06, 2024

Presentation NY Valves 2024

The BAV Genetic Map: When Is Screening and Genetic Testing Indicated?

Presenter: Siddharth K. Prakash

June 06, 2024

Presentation NY Valves 2024

Reconciling the Phenotypic and Clinical Heterogeneity of BAV Patients: GPS for the Clinician and Patient

Presenter: Hector I. Michelena

June 06, 2024

Presentation NY Valves 2024

Patient Selection: From Clinical Trials to “On Label” to Real World – Who Are the Right Candidates for LAAO?

Presenter: Samir R. Kapadia

June 06, 2024

Presentation NY Valves 2024

Where Do We Go Next?

Presenter: Roxana Mehran

June 06, 2024

Presentation NY Valves 2024

What Data and Valve Design Means for Valve Selection in Women

Presenter: Ruby Satpathy

June 06, 2024

Presentation NY Valves 2024

FX+: The Next Step in Addressing Lifetime Management

Presenter: Laura Flannery

June 06, 2024

News Conference News NY Valves 2024

Essentials for 3D-ICE in Structural Interventions Explored in Position Statement

Caitlin E. Cox

June 06, 2024

Presentation NY Valves 2024

An Evidence Based Discussion: SMART and Evolut in Women

Presenter: Howard C. Herrmann

June 06, 2024

Presentation NY Valves 2024

Not All Valves Are Designed Alike

Presenter: Matthew W. Sherwood

June 06, 2024

Presentation NY Valves 2024

Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry

Presenter: Andrea Scotti

June 06, 2024

Presentation NY Valves 2024

Cephea

Presenter: Juan F. Granada

June 06, 2024

Advertisement

The Rationale for Earlier Intervention in Aortic Stenosis

Long-term Mortality After TAVI Lower With DOACs vs VKAs

Clinical Outcomes of Consecutive Patients Treated With a Novel Transfemoral Percutaneous Mitral Valve System: A Single Center Experience

Are BAV Repair and the Ross Procedure “Better” for BAV Patients?

Aortic Valve Replacement in BAV: Biprosthesis for Everyone? When to Consider TAVR? Do We Need Thoughtful RCTs?

3D Vena Contracta Area as a Predictor of Clinical Outcomes in Transcatheter Mitral Valve Repair: A Comparative Study of MR Severity Assessment Methods

The Critical Role of Imaging in BAV Therapy Choices

Managing the BAV Valvulo-Aortopathy: Distinctive Features of BAV-AS and AR, and How to Handle the Aortopathy?

A Novel Invasive Hemodynamic Parameter (V’) to Predict Clinical Outcomes Following Mitral Transcatheter Edge-to-Edge Repair (M-TEER)

The BAV Genetic Map: When Is Screening and Genetic Testing Indicated?

Reconciling the Phenotypic and Clinical Heterogeneity of BAV Patients: GPS for the Clinician and Patient

Patient Selection: From Clinical Trials to “On Label” to Real World – Who Are the Right Candidates for LAAO?

Where Do We Go Next?

What Data and Valve Design Means for Valve Selection in Women

FX+: The Next Step in Addressing Lifetime Management

Essentials for 3D-ICE in Structural Interventions Explored in Position Statement

An Evidence Based Discussion: SMART and Evolut in Women

Not All Valves Are Designed Alike

Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry

Cephea

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content